January 22, 2021
Kyowa Pharmaceutical Industry has set off shipment controls in Japan for four generic APIs including kallidinogenase in fallout from voluntary recalls launched by other companies and due to delayed API supplies amid the COVID-19 pandemic. Subject to the measure are...read more